DealErVimmune, a Lyon, France-based biotechnology company developing next-generation therapeutic vaccines targeting HERV-derived tumor antigens, raised €17 million in a Series A fundraising round led by Seventure Partners with participation from SPRIM Global Investments.
More on StartupBusiness →
SERIES A
01/26/2026
Verismo Therapeutics, Inc., a Philadelphia, PA-based CAR-T cell therapy...
Yoga Joint, a Fort Lauderdale, FL-based hot yoga studio chain, raised $5.5...
Timeshifter, a New York-based circadian tech for jet lag, raised an...
Osteoboost Health, a Redwood City, CA-based FDA-cleared bone health...
Clean Slate Clinic, a Sydney-based virtual alcohol detox platform, raised...
Reme-D, a Cairo-based room-temperature PCR test kits company, raised...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
